Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB

906.06
MXN
+2.56
(+0.28%)
34.20EPS
Feb 04Next Earn

Swedish Orphan Biovitrum AB Documents

Q3 FY2019 · Presentation

Dova Pharmaceuticals Inc. Swedish Orphan Biovitrum AB (publ) - M&A Call · 15 pages

Read Swedish Orphan Biovitrum AB's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q3 FY2019 documents